These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 9163857)
1. Pancreas-specific protein (PASP), serum amyloid A (SAA), and neopterin (NEOP) in the diagnosis of rejection after simultaneous pancreas and kidney transplantation. Müller TF; Trösch F; Ebel H; Grüssner RW; Feiber H; Göke B; Greger B; Lange H Transpl Int; 1997; 10(3):185-91. PubMed ID: 9163857 [TBL] [Abstract][Full Text] [Related]
2. The anaphylatoxin C5a, a new parameter in the diagnosis of renal allograft rejection. Müller TF; Neumann CM; Greb C; Kraus M; Lange H Transpl Int; 1996; 9 Suppl 1():S58-62. PubMed ID: 8959792 [TBL] [Abstract][Full Text] [Related]
3. Pancreas-specific protein. New serum marker for graft rejection in pancreas-transplant recipients. Fernstad R; Tydén G; Brattström C; Sköldefors H; Carlström K; Groth CG; Pousette A Diabetes; 1989 Jan; 38 Suppl 1():55-6. PubMed ID: 2642859 [TBL] [Abstract][Full Text] [Related]
4. Noninvasive monitoring using serum amyloid A and serum neopterin in cardiac transplantation. Müller TF; Vogl M; Neumann MC; Lange H; Grimm M; Müller MM Clin Chim Acta; 1998 Aug; 276(1):63-74. PubMed ID: 9760020 [TBL] [Abstract][Full Text] [Related]
5. Clinical experience with human anodal trypsinogen (HAT) for detection of pancreatic allograft rejection. Ploeg RJ; D'Alessandro AM; Groshek M; Gange SJ; Knechtle SJ; Stegall MD; Eckhoff DE; Pirsch JD; Sollinger HW; Belzer FO Transpl Int; 1994; 7 Suppl 1():S426-31. PubMed ID: 11271272 [TBL] [Abstract][Full Text] [Related]
6. A novel assay for pancreatic cellular damage: III. Use of a pancreas-specific protein as a marker of pancreatic graft dysfunction in humans. Fernstad R; Sköldefors H; Pousette A; Groth CG; Tydén G; Ost L; Lindholm A; Carlström K Pancreas; 1989; 4(1):44-52. PubMed ID: 2654929 [TBL] [Abstract][Full Text] [Related]
7. Urinary and pancreatic juice neopterin excretion after combined pancreas-kidney transplantation. Tilg H; Königsrainer A; Krausler R; Aulitzky WE; Margreiter R; Reibnegger G; Wachter H; Huber C Transplantation; 1992 Apr; 53(4):804-8. PubMed ID: 1314440 [TBL] [Abstract][Full Text] [Related]
9. The diagnostic capacity of serum amyloid A protein for early recognition of kidney allograft rejection. Casl MT; Bulatovic G; Orlić P; Sabljar-Matovinović M Nephrol Dial Transplant; 1995 Oct; 10(10):1901-4. PubMed ID: 8592601 [TBL] [Abstract][Full Text] [Related]
10. Rejection of kidney and pancreas after pancreas-kidney transplantation. Margreiter R; Klima G; Bösmüller C; Königsrainer A; Schmid T; Steiner E Diabetes; 1989 Jan; 38 Suppl 1():79-81. PubMed ID: 2463201 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the rejection markers tumor necrosis factor, ICAM-1, neopterin, interleukin-10, and soluble HLA in simultaneous pancreas and kidney transplantation with bladder drainage. Abendroth D; Storck M; Techt B; Zavazava N Transplant Proc; 1995 Dec; 27(6):3114-5. PubMed ID: 8539869 [No Abstract] [Full Text] [Related]
12. Patterns of acute rejection in portal-enteric versus systemic-bladder pancreas-kidney transplantation. Nymann T; Hathaway DK; Shokouh-Amiri MH; Gaber LW; Abu-el-Ella K; Abdulkarim AB; Gaber AO Clin Transplant; 1998 Jun; 12(3):175-83. PubMed ID: 9642507 [TBL] [Abstract][Full Text] [Related]
13. Serum levels of pancreatic amylase and pancreas-specific protein as markers of pancreatic graft rejection episodes. Minakawa R; Brattström C; Tydén G; Tibell A; Pousette A; Bergström K Transplant Proc; 1995 Feb; 27(1):1329-30. PubMed ID: 7533379 [No Abstract] [Full Text] [Related]